| In millions, except per share items | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 | Jun-30-20 | Jun-05-20 | Mar-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 8-K | 10-Q |
| Cash flows from operating activities: | | | | | | | | |
| Net income (loss) | 17.0 | 28.0 | -31.0 | -42.0 | -8.0 | -107.0 | | -21.0 |
| Adjustments to reconcile net income (loss) to net cash from (used in) operating activities: | | | | | | | | |
| Depreciation and amortization | 33.0 | 37.0 | 38.0 | 38.0 | 39.0 | 42.0 | | 40.0 |
| Amortization of deferred costs and other assets | 1.0 | | | 1.0 | 2.0 | 4.0 | | 5.0 |
| Gain on sales of real estate | -29.0 | -42.0 | -10.0 | | -27.0 | -9.0 | | -23.0 |
| Gain on casualty | | -2.0 | -1.0 | 2.0 | -4.0 | -1.0 | -1.0 | -2.0 |
| Equity-based compensation expense | 2.0 | 3.0 | 2.0 | 2.0 | 3.0 | 3.0 | | 2.0 |
| Impairment loss | 4.0 | | | | | 56.0 | | -2.0 |
| Deferred income tax expense | | | | -4.0 | -2.0 | | | |
| Changes in assets and liabilities: | | | | | | | | |
| Accounts receivable | -1.0 | 1.0 | 1.0 | 14.0 | -8.0 | | | 2.0 |
| Other assets | 4.0 | 1.0 | 5.0 | 3.0 | 4.0 | 2.0 | | -2.0 |
| Accounts payable and accrued expenses | 2.0 | 7.0 | -1.0 | -20.0 | 1.0 | -11.0 | | 2.0 |
| Other liabilities | | | | 1.0 | -1.0 | | | |
| Net cash provided by (used in) operating activities | 33.0 | 33.0 | 3.0 | -17.0 | -1.0 | -25.0 | | 5.0 |
| |
| Cash flows from investing activities: | | | | | | | | |
| Capital expenditures, primarily investments in existing real estate | -5.0 | -5.0 | -3.0 | -6.0 | -4.0 | -5.0 | | -9.0 |
| Lender and other escrows | 2.0 | -8.0 | -2.0 | | | -8.0 | | -2.0 |
| Insurance proceeds related to real estate casualties | 2.0 | 3.0 | 2.0 | 4.0 | 2.0 | 7.0 | | 2.0 |
| Proceeds from sales of real estate | 88.0 | 131.0 | 39.0 | | 88.0 | 27.0 | | 90.0 |
| Net cash provided by investing activities | 87.0 | 121.0 | 36.0 | 41.0 | 86.0 | 21.0 | | 81.0 |
| |
| Cash flows from financing activities: | | | | | | | | |
| Proceeds from debt | | | | | | | | 110.0 |
| Repayment of debt | -102.0 | -130.0 | -41.0 | -57.0 | -94.0 | -20.0 | | -50.0 |
| Debt issuance costs | | | -1.0 | | | -1.0 | | |
| Payment of insurance financing | -3.0 | -3.0 | -1.0 | -4.0 | -4.0 | -4.0 | | -2.0 |
| Dividends on common stock | | | | | | -11.0 | | -11.0 |
| Purchase of common stock | | -1.0 | | -1.0 | | | | |
| Net cash used in financing activities | -105.0 | -134.0 | -43.0 | -62.0 | -98.0 | -36.0 | | 47.0 |
| Increase in cash and cash equivalents and restricted cash | 31.0 | | | | 80.0 | | | |
| |
| The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amount shown in the condensed consolidated statements of cash flows: | | | | | | | | |
| Cash and cash equivalents | | | | | | | | |
| Restricted cash (included in other assets) | | | | | | | | |